Format

Send to

Choose Destination
Therapie. 2017 Sep;72(4):465-474. doi: 10.1016/j.therap.2016.12.011. Epub 2017 Feb 17.

[Effectiveness of preventive treatment by Influenzinum in the winter period against the onset of influenza-like illnesses].

[Article in French]

Author information

1
Département de médecine générale, Aix-Marseille université, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France.
2
Département de médecine générale, Aix-Marseille université, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France. Electronic address: ludovic.casanova@inserm.fr.

Abstract

AIM:

In vitro Influenzinum induce a cellular change. We present the results of the first study examining the effectiveness of Influenzinum against influenza-like illnesses.

METHOD:

Retrospective cohort study during winter 2014-2015. After influenza epidemic, a self-assessment questionnaire was offered to patients presenting for a consultation. The primary endpoint was the declaration of an influenza-like illness. The exposed patients (treated by Influenzinum) were matched to two non-exposed patients (untreated) with a propensity score. A conditional logistic model expressed influenza-like illness risk reduction provided by the Influenzinum.

RESULTS:

The cohort included 3514 patients recruited from 46 general practitioners. After matching, the treated group (n=2041) and the untreated group (n=482) did not differ on variables collected. Influenzinum preventive therapy does not significantly alter the likelihood of influenza-like illness (adjusted odds ratio=0,91 [0,62 to 1,35], p=0,64).

CONCLUSION:

Influenzinum preventive therapy did not appear effective in preventing influenza-like illness.

KEYWORDS:

Active immunization; Ambulatory care; Grippe humaine; Homeopathy; Homéopathie; Human influenza; Influenzinum; Médecine ambulatoire; Propensity score; Score de propension; Vaccination

PMID:
28341159
DOI:
10.1016/j.therap.2016.12.011
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center